New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
Essential
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
FDA Watch: Natera, Valar Labs Receive FDA Clearances for Bladder Cancer Tests
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Already a member? Log in here
Compliance Corner
...
Already a member? Log in here
More Trouble for Embattled Virginia Laboratory
...
Already a member? Log in here
Effective Compliance Program Leads To Self-Disclosure for New York Hospital
...
Already a member? Log in here
Hunter Labs Loses Its Bid to Keep Entire $241 Million FCA Settlement
...
Already a member? Log in here
All False Claims Act Qui Tam Cases Will Get Criminal Reviews
...
Already a member? Log in here
Upcoming G2 Events
...
Already a member? Log in here
News-At-A-Glance: LabMD vs. FTC Update
...
Already a member? Log in here